Set Therapeutics Inc.
Somerville, MA
- UEI
- TJ7QJLPM1JM6
- CAGE
- 11SM1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 65 Hall Ave, Somerville, MA 02144, USA
- Website
- settx.bio
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: isolating and reformatting immune receptors into targeting therapies for oncology, auto-immunity, and… | National Science Foundation | $305,000 |
Quick answers
Is Set Therapeutics Inc. registered in SAM.gov?
Yes. Set Therapeutics Inc.'s SAM.gov registration is active through April 2, 2027.
What is Set Therapeutics Inc.'s most recent federal award?
Set Therapeutics Inc.'s most recent federal grant award is Sbir phase i: isolating and reformatting immune receptors into targeting therapies for oncology, auto-immunity, and… (2537433), from National Science Foundation, on July 1, 2026.
On GovTribe
See Set Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors